James B. McNally

US·SEC (Form 4)

GenMark Diagnostics, Inc.

Cumul. flow

Total declarations

Company

▲ Purchases (0 ops.)

—

▼ Sales (19 ops.)

€206k

Latest filing published 26 Nov 2019 for GenMark Diagnostics, Inc., €11k.

Filing timeline

BuySale

James B. McNally

Insider track record

Disclosed buys

Disclosed sells

Signal history

James B. McNally: trading record in brief

James B. McNally appears in our data through filings on GenMark Diagnostics, Inc. shares, published by SEC (Form 4). In total, 26 filings cover trades dated from 2 November 2016 to 25 November 2019.

The open-market record consists of 19 sales worth €206k, with no purchase. Besides market trades, the filings include 6 share grants and 1 option exercise. 2019 to date brings no purchases and 10 sales.

Most recently, on 26 November 2019, the filings show an open-market sale worth €11k in GenMark Diagnostics, Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. For comparison, the SEC allows two business days to file a Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.

Companies and markets linked to James B. McNally

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

GenMark Diagnostics, Inc. (US)

Declarations26 total

▼
James B. McNally
SVP, Marketing and Bus. Dev.Executives25 Nov 2019GenMark Diagnostics, Inc.
12,424 USD30SEC
2,288 shares@ US$5.436.5% of flowCommon StockSEC:0001487371-19-000269:0
▼
James B. McNally
SVP, Marketing and Bus. Dev.Executives5 Nov 2019GenMark Diagnostics, Inc.
5,328 USD26SEC
938 shares@ US$5.682.7% of flowCommon StockSEC:0001487371-19-000236:0
▼
James B. McNally
SVP, Marketing and Bus. Dev.Executives30 Oct 2019GenMark Diagnostics, Inc.
10,102 USD24SEC
1,718 shares@ US$5.885.2% of flowCommon StockSEC:0001487371-19-000221:0
▼
James B. McNally
SVP, Marketing and Bus. Dev.Executives27 Aug 2019GenMark Diagnostics, Inc.
13,845 USD30SEC
2,296 shares@ US$6.037.0% of flowCommon StockSEC:0001487371-19-000208:0
▼
James B. McNally
SVP, Marketing and Bus. Dev.Executives5 Aug 2019GenMark Diagnostics, Inc.
5,905 USD26SEC
1,006 shares@ US$5.872.9% of flowCommon StockSEC:0001487371-19-000186:0
▼
James B. McNally
SVP, Marketing and Bus. Dev.Executives30 May 2019GenMark Diagnostics, Inc.
13,576 USD30SEC
2,057 shares@ US$6.606.8% of flowCommon StockSEC:0001487371-19-000149:0
▼
James B. McNally
SVP, Marketing and Bus. Dev.Executives24 May 2019GenMark Diagnostics, Inc.
1,529 USD29SEC
231 shares@ US$6.620.8% of flowCommon StockSEC:0001487371-19-000139:0
▼
James B. McNally
SVP, Sales and MarketingExecutives3 May 2019GenMark Diagnostics, Inc.
7,229 USD26SEC
928 shares@ US$7.793.6% of flowCommon StockSEC:0001487371-19-000097:0
▼
James B. McNally
SVP, Sales and MarketingExecutives25 Feb 2019GenMark Diagnostics, Inc.
83,497 USD33SEC
12,297 shares@ US$6.7939.3% of flowCommon StockSEC:0001487371-19-000062:0
◆
James B. McNally
SVP, Sales and MarketingExecutives18 Feb 2019GenMark Diagnostics, Inc.
0SEC
101,250 shares0Common StockSEC:0001487371-19-000046:0
▼
James B. McNally
SVP, Sales and MarketingExecutives23 Jan 2019GenMark Diagnostics, Inc.
27,907 USD30SEC
4,730 shares@ US$5.9013.1% of flowCommon StockSEC:0001487371-19-000026:0
◇
James B. McNally
SVP, Sales and MarketingExecutives17 Jan 2019GenMark Diagnostics, Inc.
0SEC
11,428 shares0Common StockSEC:0001487371-19-000014:0
▼
James B. McNally
SVP, Sales and MarketingExecutives27 Nov 2018GenMark Diagnostics, Inc.
1,113 USD29SEC
219 shares@ US$5.080.5% of flowCommon StockSEC:0001487371-18-000231:0
▼
James B. McNally
SVP, Sales and MarketingExecutives5 Nov 2018GenMark Diagnostics, Inc.
7,973 USD29SEC
1,644 shares@ US$4.853.4% of flowCommon StockSEC:0001487371-18-000202:0
◆
James B. McNally
SVP, Sales and MarketingExecutives26 Oct 2018GenMark Diagnostics, Inc.
0SEC
20,000 shares0Common StockSEC:0001487371-18-000200:0
▼
James B. McNally
SVP, Marketing & Bus DevExecutives24 Aug 2018GenMark Diagnostics, Inc.
1,647 USD29SEC
230 shares@ US$7.160.7% of flowCommon StockSEC:0001487371-18-000183:0
▼
James B. McNally
SVP, Marketing & Bus DevExecutives3 Aug 2018GenMark Diagnostics, Inc.
4,896 USD29SEC
680 shares@ US$7.202.0% of flowCommon StockSEC:0001487371-18-000155:0
▼
James B. McNally
SVP, Marketing & Bus DevExecutives23 May 2018GenMark Diagnostics, Inc.
1,486 USD29SEC
216 shares@ US$6.880.6% of flowCommon StockSEC:0001487371-18-000114:0
▼
James B. McNally
SVP, Marketing & Bus DevExecutives2 May 2018GenMark Diagnostics, Inc.
4,876 USD29SEC
789 shares@ US$6.182.0% of flowCommon StockSEC:0001487371-18-000089:0
◆
James B. McNally
SVP, Marketing & Bus DevExecutives23 Feb 2018GenMark Diagnostics, Inc.
0SEC
102,750 shares0Common StockSEC:0001487371-18-000052:0
▼
James B. McNally
SVP, Marketing & Bus DevExecutives26 Feb 2018GenMark Diagnostics, Inc.
4,387 USD29SEC
1,052 shares@ US$4.171.7% of flowCommon StockSEC:0001487371-18-000052:1
▼
James B. McNally
SVP, Marketing & Bus DevExecutives2 Feb 2018GenMark Diagnostics, Inc.
4,350 USD29SEC
848 shares@ US$5.131.7% of flowCommon StockSEC:0001487371-18-000020:0
▼
James B. McNally
SVP, Marketing & Bus DevExecutives2 Nov 2017GenMark Diagnostics, Inc.
22,328 USD30SEC
3,084 shares@ US$7.249.3% of flowCommon StockSEC:0001487371-17-000226:0
◆
James B. McNally
SVP, Marketing & Bus DevExecutives27 Oct 2017GenMark Diagnostics, Inc.
0SEC
10,000 shares0Common StockSEC:0001487371-17-000199:0
◆
James B. McNally
SVP, Marketing & Bus DevExecutives22 Feb 2017GenMark Diagnostics, Inc.
0SEC
10,000 shares0Common StockSEC:0001487371-17-000054:0

25 of 26 declarations

James B. McNally

Insider track record

James B. McNally: trading record in brief

Companies and markets linked to James B. McNally

Similar companies

Related executives